This report provides an analysis for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market ...
Our fair value estimate for Ansys is $327 per share, based on its pending deal to be acquired by Synopsys. Ansys shareholders will receive $197 in cash and 0.345 shares of Synopsys stock for each ...
Facing high employee turnover and an aging population, nursing homes have increasingly turned to robots to complete a variety of care tasks, but few researchers have explored how these technologies ...